Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Across the Margin: The Podcast

Episode 36: Psychedelic Integration with Katherine MacLean

16 Nov 2017

Description

In this episode of Beyond the Margin, host Michael Shields welcomes in studio Katherine MacLean, a research psychologist with expertise in studying psychedelics and meditation. Katherine is the founding director of the Psychedelic Program of New York where she leads trainings in psychedelic harm reduction. A true and passionate psychedelic ambassador, Katherine has worked with MAPS (Multidisciplinary Association of Psychedelic Studies), The Center for Optimal Living, and the Brooklyn Psychedelic Society in order to further psychedelic research and offer patients a safe place to receive treatment and education. Her Ted Talk entitled “Open Wide and Say Awe” details the ways in which psychedelics allow for deeply enriching experiences with long lasting improvements in well-being, greater confidence in making life changes, and reductions in psychedelic distress, and .In the podcast Michael and Katherine discuss Katherine’s extensive research background and experiences with psychedelics, the reasons for, and benefits of, psychedelic integration, the stigmas surrounding psychedelics, RAFT meditation (a process she originated), microdosing, “openness to experience,” the potential benefits of psychedelic use, and much, much more. So dive deep as Beyond the Margin examines a tool that could possibly, and profoundly, enrich lives with one of the foremost experts on the topic!Subscribe to Across the Margin: The PodcastCheck out Across the Margin the magazine for exciting stories & much, much more! Hosted on Acast. See acast.com/privacy for more information.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.